1. The effect of chronic and acute administration of amphotericin B on renal function, especially urinary acidification, was studied in rats. Chronic intraperitoneal administration of amphotericin B resulted in blood concentrations similar to or higher than those seen in patients treated with the antibiotic, but failed to produce hyperchloraemic acidosis. The minimum urine pH achieved during NH,Cl-induced acidosis was significantly higher in amphotericin-treated rats than in controls; net acid excretion, however, was not significantly different from that of controls. These data were interpreted as indicating the presence of an incomplete distal acidification defect.
3.
In order to investigate the effect of large concentrations of amphotericin on distal H+ secretion, amphotericin was administered acutely to HC0;-loaded rats. Acute intravenous administration of amphotericin resulted in a significant decrease in (U-B)Pco, and urine HCO; concentration; the decrease in urinary Pco, was of greater magnitude than the decrease in urine HCO? concentration, leading to a rise in urine pH. The maximum urine pH achieved during HCO; loading (maximal urine HCO; was the same in both groups) was significantly higher in the animals infused acutely with amphotericin than in controls, thus indicating that amphotericin-treated animals have a distal acidification defect. These data are compatible with the hypothesis that amphotericin induces an acidification defect by increasing H+ back-diffusion in the form of carbonic acid or dissolved CO, when the urine is highly alkaline and in
Introduction
Amphotericin B is widely used for the treatment of systemic fungal infections (Butler, Bennett, Alling, Wertlake, Utz & Hill, 1964a) . Administration of this antibiotic, however, is associated with nephrotoxic side-effects: in particular, development of N . K . Julka, J. A. L. Arruda and N . A. Kurtzman renal failure, renal tubular acidosis and hypokalaemia (Burgess & Birchall, 1972; Butler et al., 1964a; Douglas & Healy, 1969; McCurdy, Frederic & Elkinton, 1968; Patterson & Ackerman, 197 I) . Chronic intraperitoneal administration of amphotericin B to rats has been reported to result in nephrotoxic effects identical with those reported in man (Gouge & Andriole, 1971) . Steinmetz & Lawson (1970) demonstrated that the addition of amphotericin B to the mucosal surface of the urinary bladder of the turtle results in an increased permeability of this membrane to H+ and K+. They suggested that the same mechanism may be operative in patients with amphotericin-induced renal tubular acidosis.
More recently, measurement of urine-blood (U-B)Pco, during alkalinization of the urine has been used to assess distal acidification (Arruda, Nascimento, Kumar & Kurtzman, 1977a; Arruda, Nascimento, Mehta, Rademacher, Sehy, Westenfelder & Kurtzman, 1977b; Halperin, Goldstein, Haig, Johnson & Stinebaugh, 1974) . As can be seen from the equation:
H+ secretion during alkalinization of the urine will result in a shift of equilibrium of the reaction to the right with consequent elevation of carbonic acid. Owing to the absence of carbonic anhydrase on the luminal epithelial surface of the distal nephron there is delayed dehydration of carbonic acid, which dissociates into CO, and H,O in the postpapillary region. In the lower urinary tract, the volume-to-surface relationship is unfavourable for CO, diffusion, resulting in a rise in urinary PCO, (Arruda et al., 1977b) . The failure to raise (U-B)Pco, has been suggested to indicate either diminished H+ secretion (secretory defect), by some investigators (Halperin et al., 1974) , or enhanced carbonic acid back-diffusion (gradient defect) by others (Sebastian, McSherry & Morris, 1976) . It is likely that both types of acidification defect will be associated with the inability to raise (U-B)Pco, (Arruda ef al., 1977a) . Roscoe, Goldstein, Halperin, Schloeder & Stinebaugh (1977) reported that chronically amphotericin-treated rats raise urinary Pco, normally during alkalinization of the urine. In this study we examined the effects of chronic and acute amphotericin B administration to rats; we studied their ability to both raise urinary Pco, and acidify the urine.
Methods
Experiments were performed on Sprague-Dawley male rats weighing 250-400 g. The rats were allowed a normal food and water intake before the day of study. They were anaesthetized with Inactin (Promonta, Hamburg, West Germany) given intraperitoneally (10 mg/100 g). Tracheostomy was performed and one carotid artery and one jugular vein were cannulated. The bladder was catheterized through an abdominal incision. Blood pressure was monitored throughout the experiment. At the start of the experiment [12511iothala-mate, diluted in sodium chloride solution (saline), 0.75 ,uCi/ml, was given by an infusion pump at a rate of 0.024 ml/rnin throughout the course of the experiment as a marker of GFR. An equilibration period of 60 min was allowed before any collection was started. Urine samples were collected under mineral oil in preweighed glass vials and the urine volume was determined gravimetrically. Blood samples were collected from the carotid artery at the mid-portion of each clearance collection; collections were of 10-30 min duration.
Chronic amphotericin treatment was administered by injecting 5 mg of amphotericin B/kg (5.4 ymollkg) intraperitoneally (average of five injections/week). The rats received an average of 23.0 k 10.8 injections (range 8-50) given during a period of 10-60 days. Rats with a blood urea concentration greater than 18 mmol/l at the time of the study were discarded. The following groups of rats were studied.
Group 1: chronic amphotericin administration +
NH,Cl
This group was studied to determine whether animals treated chronically with amphotericin have a defect in lowering urine pH maximally in response to acidosis, as has been reported by other investigators (Gouge & Andriole, 1971; Roscoe et al., 1977) . The rats used in this group were fed with 1.5% (0.28 mol/l) NH,Cl solution for at least 3 days before the study. The following groups of animals were studied.
Group 1A (chronic amphotericin B administration): six rats chronically treated with amphotericin B were prepared for clearance studies as described above. Two to three clearance collections were obtained.
Group 1B (normal rats): six normal rats were prepared for the clearance study. Two to three collections were obtained.
Group 2: chronic amphotericin administration +

NaHCO, loading
This group of animals was studied to determine whether animals treated chronically with amphotericin have a defect in raising urine Pco, in response to HCO, loading.
Forty rats chronically treated with amphotericin B were included in this study (groups 2B and 2C).
For at least 3 days preceding the study these rats were fed with 1.5% (0.28 mol/l) NH,Cl solution in order to produce metabolic acidosis. The animals were prepared for clearance studies as described above. After baseline urine and blood collections the rats were infused with NaHCO, solution (0.9 mol/l) at a rate of approximately 6 ml/h in order to achieve a urine pH greater than 7.8; once this urine pH was achieved two to three urine and blood collections were obtained. An additional four rats were injected with sodium deoxycholate, the vehicle used to dissolve amphotericin B (group 2A).
Group 3: acute intravenous amphotericin iflusion + NaHCO, loading
This group was studied in an attempt to achieve higher concentrations of amphotericin B in the urine and thus simulate conditions present in the studies in vitro, where an acidification defect induced by amphotericin is easily demonstrable (Steinmetz & Lawson, 1970; Finn, Cohen & Steinmetz, 1977) . This protocol is different from those used by previous investigators, who studied only animals chronically treated with amphotericin B (Gouge & Andriole, 1971 ; Roscoe et al.,
1977).
Group 3A: acute sodium deoxycholate administration. Nine rats were treated identically with those of group 3B, except that they were infused intravenously with sodium deoxycholate (the vehicle used to dissolve amphotericin) instead of amphotericin B. The volume infused was identical with that used in group 3. Since acute amphotericin administration to the previous group of rats resulted in a significant increase in serum K+, KCl was infused at a rate of 1 mmol/h simultaneously with sodium deoxycholate.
Group 3B: acute amphotericin B administration. Twenty-four rats were studied in this group. The rats were infused with NaHCO, solution (0.9 mol/l) as described above. When the urine pH achieved a value greater than 7.8 two to three urine and blood collections were obtained. Amphotericin B was then infused intravenously at a dose of 2 mg h-' kg-' (2.2 pmol h-' kg-') for 60 min and further collections were obtained. Fourteen rats received amphotericin B in a concentration of 2 m g / d (2.2 pmol/ml) and the other 10 in a concentration of 0.5 mg/ml(O-54 pmol/ml).
Group 4: other studies
This group was studied to determine whether animals chronically treated with amphotericin develop metabolic acidosis and to determine blood concentrations of amphotericin.
Ten rats chronically treated with amphotericin B were exsanguinated through the abdominal aorta; amphotericin blood concentrations were determined in six rats and arterial blood pH and Pa,co, measured in six rats (both determinations were made in two of the rats).
GFR, plasma and urine electrolyte determinations were performed as previously described (Kurtzman, 1970) . Ammonia and titratable acid were measured by the method of Cunarro t Weiner (1974). Amphotericin blood concentrations were measured by bioassay (Louria, 1958) . Carbonic anhydrase activity in the urine was assayed by the method of Maren (1970) .
The amphotericin B used in the study was provided by E. R. Squibb and Sons (New York), either as a commercial preparation of amphotericin B (Fungizone) or as a pure powder of amphotericin. The pure powder was prepared with sodium deoxycholate according to the same method as that used for the preparation of Fungizone.
The data were analysed by the t-test for paired and unpaired groups (Kurtzman, 1970) . Statistical significance was defined as P < 0.05.
Results
NH,Cl
The mean plasma urea concentration of all chronically amphotericin-treated rats was 10.7 & 1.33 mmol/l. There was no difference in GFR, urine flow and blood pH between the two groups. The minimum urine pH was significantly greater in amphotericin-treated rats than in the control group. Titratable acid excretion, NH: excretion and net acid excretion were not significantly different between the two groups.
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Group 2: chronic amphotericin administration +
NaHCO, loading
The mean baseline urine pH of all chronically amphotericin-treated rats after NH4C1 administration in group 2 was 5.75 f 0-03 at a blood pH of 7.26 f 0.03. The urine pH in this group was significantly higher than that of control rats shown in Table 1 (P < 0.001). When data of all the amphotericin B-treated rats taken as one single group were compared with those of the control groups there was no significant difference between them. Analysis of the data of amphotericin-treated animals, however, showed that this group was not homogeneous. Group 2B included rats which were able to raise their (U-B)Pco, gradient to the same level as controls (group 2A), and group 2C rats failed to raise (U-B)Pco, maximally (less than 15 mmHg or 2-0 kPa) ( Table 2) .
In chronically amphotericin-treated rats with a decreased G F R and (U-B)Pco, (group 2C) urine H C 0 7 concentration was lower than that of control rats and lower than that of group 1A amphotericin-treated rats. The maximal urine pH achieved, however, was not different from that of the other two groups.
Group 3: acute intravenous amphotericin infusion + NaHCO, loading During NaHCO, administration both groups of rats were able to increase urine pH, urine HCOr concentration and (U-B)Pco, normally. Infusion of amphotericin B intravenously resulted in a significant decrease in G F R and fractional K+ excretion and an increase in plasma K+ concentrations (group 3B). Acute amphotericin infusion led to a significant decrease in (U-B)Pco,; urine HCO; concentration decreased slightly, although significantly, and urine pH rose significantly. At comparable urinary HCO; concentrations the maximal urine pH achieved was significantly higher during amphotericin infusion than in the control group. There was no detectable carbonic anhydrase in the urine samples collected from four rats infused with amphotericin.
The control group of rats infused with sodium deoxycholate plus KCl (group 3A) did not show any significant change in GFR, urine pH, urine HCO; concentration or fractional K+ excretion. (U-B)Pco, decreased slightly but the difference did not achieve statistical significance (Table 3 ).
Group 4: other studies
Blood concentrations of amphotericin were measured in six rats chronically treated with the drug; the mean value was 3.0 f 0.45 p g / d (0-003 k 0.0004 pmol/ml).
Blood pH and blood Pa,co, were 7-46 f 0.02 and 26.0 & 3.67 mmHg (3.5 f 0.49 kPa) respectively in six chronically amphotericin-treated rats which did not receive NH4Cl administration.
Discussion
The results of this study demonstrate that chronically amphotericin-treated rats, when compared with control animals, have impaired ability to lower urine p H during NH4C1-induced acidosis; NH: excretion and net acid excretion, however, were not different from those of controls. These data are similar to those of Gouge & Andriole (197 1) and Roscoe et al. (1977) .
The interest in studying urinary Pco, in amphotericin-treated rats arose from the fact that this drug has been shown to increase the permeability of the turtle bladder, mammalian cells and other 
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Group 1B membranes to cations (Cass, Finkelstein & Krespi, 1970; Steinmetz & Lawson, 1970) . These observations suggested that increased back-diffusion of H+ from the tubular lumen of the distal nephron may represent the pathogenic mechanism in the clinical syndrome of distal renal tubular acidosis induced by amphotericin. Roscoe et al. (1977) found the ability to raise urinary Pco, was normal in amphotericin-treated rats. They interpreted these findings as indicating that the distal acidification defect of amphotericin administration was not associated with increased carbonic acid back-diffusion. In our study 85% of amphotericin-treated rats were able to raise (U-B)Pco, normally, whereas the remaining 15% had an abnormally low (U-B)Pco,. It should be emphasized that the mean (U-B)Pco, of all chronically amphotericin B-treated rats was not significantly different from that of control rats. The decrease of (U-B)Pco, observed in 15% of the chronically amphotericin-treated animals is likely to have been the result of the decreased urinary HCO; concentration, secondary to the concentrating defect of renal insufficiency or amphotericin (Steinmetz, Al-Awquati & Lawson, 1970; Arruda et al., 1977b) . Our data to this point are thus in complete agreement with those reported by Roscoe et al. (1977) . The fact that the majority of all amphotericin-treated animals are able to raise (U-B)Pco, normally, while having impaired ability to lower urine pH and normal net acid excretion, has two possible interpretations. First, the acidification defect induced by amphotericin (i.e. increased H+ back-diffusion) could be associated with a normal ability to raise (U-B)Pco, because H,CO, does not back-diffuse, or second, the acidification defect induced by amphotericin could be incomplete, i.e. there is an inability to lower the urine pH maximally during acidosis but H+ secretion is normal when the blood pH is normal or elevated (Wrong & Davies, 1959) .
In order to investigate further the mechanism of amphotericin on distal acidification, the effect of acute infusion of large doses of amphotericin to HC0;-loaded rats was studied. It was reaioned that these larger doses of amphotericin might result in a concentration of amphotericin in the distal nephron similar to that used in the turtle bladder and thus cause a more severe distal acidification defect. Acute infusion of amphotericin resulted in a significant decrease in urinary Pco,, urinary HCO; and GFR, whereas plasma K+ increased significantly. The increase in serum K+ reflects an increased permeability of the membrane of erythrocytes and the decrease in GFR is the result of the vasoconstrictor effect of this drug (Butler, Bennett, Hill, Szwed & Cotlove, 1964b; Butler, Hill, Szwed & Knight, 1964c; Butler, Alling & Cotlove, 1965; Butler & Cotlove, 1971) . The decrease in fractional K+ excretion probably reflects an unsteady state due to the decrease in GFR.
We have recently demonstrated that urinary PCO, in highly alkaline urine is critically dependent on urinary HCO; concentration (Arruda et al., 1977b) . If the decrease in urinary HCO; concentration is the primary event, the urinary Pco, will decrease in the same proportion and urine pH will remain unchanged. On the other hand, if the decrease in urinary Pco, is the primary event, urinary HCO; will either remain unchanged or decrease slightly, secondary to the shift in equilibrium to the right of the reaction:
Since the decrease in urinary Pco, is of greater magnitude than the decrease in urine HCO; concentration, the urine pH would rise. An increase in urine pH in highly alkaline urine associated with a fall in urinary Pco, has three possible interpretations: (1) the presence of carbonic anhydrase in the urine (Arruda, Roseman, Sehy, Mehta & Kurtzman, 1977~) ; (2) failure to secrete H+ (secretory defect); (3) increased carbonic acid back-diffusion (gradient defect). Since there was no carbonic anhydrase activity in the urine during acute amphotericin infusion the decrease in (U-B)Pco, and increase in urine pH observed must indicate the presence of a distal acidification defect. The data obtained during acute intravenous infusion of amphotericin are thus strikingly different from those obtained during chronic amphotericin administration, suggesting that the large dose of amphotericin administered intravenously disclosed an acidification defect not elicited by chronic administration of this antibiotic. The fact that, in the turtle bladder, amphotericin causes an acidification defect by increasing passive back-diffusion of H+ (Steinmetz et al., 1970) , strongly suggests that the decrease in urinary PCO, observed during HCO; loading in uiuo is also the result of increased back-diffusion of H,CO,.
The decline in (U-B)Pco, however, cannot be attributed to hyperkalaemia, since we previously demonstrated that an increase in serum K+ does not affect (U-B)Pco, (Arruda et al., 1977a) ; furthermore, infusion of KC1 to animals receiving deoxycholate did not lower urinary Pco,.
In conclusion, these data demonstrate that N. K. Julka, J. A. L. Arruda and N. A . Kurtzman chronic amphotericin treatment is associated with impaired ability to lower urine pH during acidosis and normal ability to raise [GB)Pco, in highly alkaline urine. The data suggest that chronic amphotericin treatment causes an incomplete form of distal acidification defect which is only evident during acidosis. Acute intravenous amphotericin infusion produces a more profound defat, which results in a decrease in (U-B)Pco, and an increase in urine pH. The fall in urinary Pco, is probably the result of increased carbonic acid back-diiusiun. Thus the acidification defect induced by amphotericin both in vivo and in vitro appears to be the result of altered membrane permeability.
